Raymond S. Koff

Raymond S. Koff's AcademicInfluence.com Rankings

Raymond S. Koff

Philosophy

#7864

World Rank

#11137

Historical Rank

Logic

#4901

World Rank

#6238

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Raymond S. Koff's Degrees

Doctorate Medicine University of Medicine and Dentistry of New Jersey

Why Is Raymond S. Koff Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Raymond S. Koff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. (2000) (548)
Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine (1995) (480)
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product (1996) (437)
Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring (2000) (394)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. (2007) (276)
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. (1978) (275)
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease (1998) (261)
Cost-effectiveness of Interferon-2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B (1995) (218)
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. (1987) (212)
Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. (1998) (189)
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis (2000) (167)
Clinical manifestations and diagnosis of hepatitis A virus infection. (1992) (155)
Nonsteroidal anti‐inflammatory drug use in relation to major upper gastrointestinal bleeding (1993) (126)
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption (1999) (126)
The Therapeutic Use of Acetaminophen in Patients with Liver Disease (2005) (123)
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (2014) (120)
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. (2002) (111)
National Academy of Clinical Biochemistry Standards of Laboratory Practice : Laboratory Guidelines for Screening , Diagnosis and Monitoring of Hepatic Injury (2001) (97)
Seroepidemiology of hepatitis A in the United States. (1995) (92)
Alcohol consumption and the risk of major upper gastrointestinal bleeding. (1995) (80)
Contagiousness of acute hepatitis B. Secondary attack rates in household contacts. (1977) (79)
Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. (1994) (73)
CASE REPORT: Cholestatic Hepatitis Induced by Epstein-Barr Virus Infection in an Adult (2003) (71)
Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. (1995) (69)
Immunogenicity of hepatitis B vaccines: implications of immune memory. (2002) (69)
Carcinoembryonic antigen levels in benign and malignant pleural effusions. (1978) (67)
Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. (1984) (67)
Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. (1986) (67)
Impaired health‐related quality of life in chronic hepatitis C: The how, but not the why (1999) (65)
Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature. (1978) (64)
Internal temperature of steamed clams. (1967) (64)
Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. (1977) (64)
Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. (1993) (63)
Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. (1976) (63)
Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. (1967) (60)
Phlebotomy Improves Therapeutic Response to Interferon in Patients with Chronic Hepatitis C: A Meta-Analysis of Six Prospective Randomized Controlled Trials (2008) (59)
Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [Science 1973;182:1026-1028]. (2002) (58)
Regional variation in the cost effectiveness of childhood hepatitis A immunization (2003) (56)
Carcinoembryonic antigen assay of ascites and detection of malignancy. (1978) (55)
D-Galactosamine Hepatitis I. Hepatocellular Injury and Fatty Liver Following A Single Dose (1971) (54)
A phase I/II study of recombinant human interleukin‐12 in patients with chronic hepatitis C (1999) (52)
Necrotizing angiitis in a methamphetamine user with hepatitis B--angiographic diagnosis, five-month follow-up results and localization of bleeding site. (1973) (43)
Changing concepts in the epidemiology of viral hepatitis. (1968) (41)
Separation of derivatized glycosphingolipids into individual molecular species by high performance liquid chromatography. (1989) (39)
Toxicity From Repeated Doses of Acetaminophen in Children: Assessment of Causality and Dose in Reported Cases (2014) (37)
The case for routine childhood vaccination against hepatitis A. (1999) (36)
The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A (2002) (35)
Gastroenterologist Specialist Care and Care Provided by Generalists—An Evaluation of Effectiveness and Efficiency (2003) (34)
A Note on Fatality in Serum Hepatitis (1965) (34)
Pretreatment evaluation of chronic hepatitis C - Risks, benefits, and costs (1999) (33)
Herbal hepatotoxicity. Revisiting a dangerous alternative. (1995) (32)
D-Galactosamine Hepatotoxicity II. Mechanism of Fatty Liver Production 1 (1971) (30)
Lactic acidosis in oat cell carcinoma with extensive hepatic metastases. (1978) (28)
Pathogenesis of Experimental Viral Hepatitis (1974) (28)
Health hazards of bivalve-mollusk ingestion. (1975) (28)
Absence of an age effect on sulfobromophthalein retention in healthy men. (1973) (28)
Long-term hepatic memory for hypersensitivity to nitrofurantoin. (1992) (28)
Isolated elevation of serum alkaline phosphatase level in an uncomplicated pregnancy: a case report. (2000) (27)
Hepatitis vaccines: recent advances. (2003) (26)
Review article: vaccination and viral hepatitis – current status and future prospects (2007) (25)
Thorotrast and the liver: a reminder. (1975) (24)
Cholestasis and toxic epidermal necrolysis associated with phenytoin sodium ingestion: the role of bile duct injury. (1981) (24)
Peliosis hepatis in hematologic disease. Report of two cases. (1978) (23)
Prevention of the ethanol-induced fatty liver in the rat by phenobarbital. (1970) (23)
D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liver. (1976) (23)
In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease. (1981) (23)
Primary liver cancer: Etiological and progression factors (1995) (22)
Management of the hepatitis B surface antigen (HBsAg) carrier. (1981) (22)
Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia. (1980) (20)
The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. (2002) (19)
Tumors of the liver and intrahepatic bile ducts. In Atlas of Tumor Pathology, Second Series, Fasc. 26. By John R. Craig, Robert L. Peters and Hugh A. Edmondson, 280 pp. Washington, DC: Armed Forces Institute of Pathology, 1990. $35.00 (1991) (19)
Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States. (1995) (19)
Enterically transmitted non-A, non-B hepatitis: importation from Mexico to Massachusetts. (1989) (19)
The low efficiency of maternal-neonatal transmission of hepatitis C virus: how certain are we? (1992) (18)
Interferon- for Chronic Hepatitis C: Reducing the Uncertainties (1997) (18)
Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies. (1981) (17)
Causes of increased plasma creatine kinase activity after surgery. (1974) (16)
Chlorpromazine inhibition of ethanol metabolism without prevention of fatty liver. (1972) (15)
Polycythemia vera with myelofibrosis and myeloid metaplasia. Acute hepatic failure following splenectomy. (1980) (15)
Infectious diseases of humans: Dynamics and control. By R.M. Anderson and R.M. May, 757 pp. Oxford: Oxford University Press, 1991. $95.00 (1992) (15)
D-galactosamine hepatotoxicity. 3. Normoactive smooth endoplasmic reticulum and modification by phenobarbital. (1973) (15)
Cost-effectiveness of treatment for chronic hepatitis C. (1999) (15)
Hepatitis B school-based vaccination programmes in the USA: a model for hepatitis A and B. (2000) (14)
Preventing hepatitis A infections in travelers to endemic areas. (1995) (14)
Underreporting of Viral Hepatitis (1973) (14)
Circulating CEA levels in patients with fulminant hepatitis (1982) (14)
Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: Promises and limitations (1995) (14)
α-Fetoprotein glycosylation is abnormal in some hepatocellular carcinomas, including white patients with a normal α-fetoprotein concentration (1993) (14)
Prevention of hepatitis C virus infection. (1997) (13)
Immunogenicity of hepatitis B vaccines. (1994) (13)
Cirrhosis: A Practical Guide to Management. (2015) (13)
Hepatitis B today: clinical and diagnostic overview. (1993) (12)
Sensori-neural hearing loss in alcoholic cirrhosis. (1973) (12)
An economic assessment of pre-vaccination screening for hepatitis A and B. (2003) (12)
Cost-effectiveness of combined interferon and ribavirin versus interferon alone. (1999) (12)
Intraperitoneal Halothane Administration: Evidence of Hepatic and Muscle Injury 1 (1971) (11)
Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs. (1998) (11)
REVIEW: Hepatitis A, Hepatitis B, and Combination Hepatitis Vaccines for Immunoprophylaxis: An Update (2002) (10)
Chronic active hepatitis without hepatitis B antigenemia in renal transplant recipients. Report of three cases. (1974) (10)
Nonspecific lipid transfer protein in the assay of a membrane-bound enzyme CMP-N-acetyl-neuraminate:lactosylceramide sialyltransferase. (1988) (10)
Multidrug resistance in cancer cells: Biochemical mechanisms (1989) (9)
Benefit of endoscopy in upper gastrointestinal bleeding in patients with liver disease (1981) (9)
Successful intravenous cholecystocholangiography in the jaundiced patient using meglumine iodoxamate (Cholovue). (1976) (9)
Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs (1998) (9)
Gastroenterologist specialist care and care provided by generalists--an evaluation of effectiveness and efficiency. (2003) (9)
An Economic Assessment of Pre-Vaccination Screening for Hepatitis A and B (2003) (9)
Chronic hepatitis C: early intervention. (1998) (9)
Neuropsychological dysfunction in acute viral hepatitis. (1979) (9)
Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable. (1995) (8)
Hepatic encephalopathy: Syndromes and therapies. Edited by H.O. Conn and J. Bircher, 429 pp. Bloomington, IL: Medi-Ed Press, 1994. $63.95 (1994) (8)
Cost‐effectiveness of hepatitis A vaccination in patients with chronic hepatitis C (2000) (8)
Hepatitis A and Non‐A, Non‐B Viral Hepatitis in São Paulo, Brazil: Epidemiological, Clinical, and Laboratory Comparisons in Hospitalized Patients (2007) (8)
Passive and active immunoprophylaxis of hepatitis B. (1984) (8)
VACCINES AND HEPATITIS B (1999) (8)
Advances in the treatment of chronic viral hepatitis. (1999) (8)
Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen. (1996) (8)
Acute and chronic giant cell hepatitis: a paramyxovirus infection? (1991) (7)
Terbinafine-induced hepatitis and pancytopenia. (2001) (7)
Hepatology: A textbook of liver diseases. 2nd ed. Edited by D. Zakim and T.D. Boyer, 1,568 pp. Philadelphia: W.B. Saunders Co., 1989. $225 per set (1991) (7)
[Salicylate hepatitis]. (1978) (7)
Ascites following renal transplantation (1977) (7)
Proliferative and secretory B cell activity in severe alcoholic liver disease (1978) (6)
The hepatitis knowledge base (short form). (1980) (6)
Hepatic hemosiderosis after portacaval shunt surgery in alcoholic cirrhosis: a sometime thing. (1972) (6)
Fulminant hepatitis due to HBV/HDV coinfection. (1987) (5)
Chylous ascites in adults. (1985) (5)
Disappearance and prolonged absence of jaundice and hyperbilirubinemia in carcinoma of the ampulla of Vater. (1973) (5)
Disease Management Programs for Hepatitis C (2001) (5)
Epidemiology of viral hepatitis (1970) (5)
Alcohol in cough medicines hazard to disulfiram user. (1971) (5)
Problem hepatitis viruses: the mutants. (1994) (5)
Fundamentals of lung auscultation. (2014) (5)
Lactosylceramide molecular species specificity of rat liver CMP-N-acetylneuraminate:lactosylceramide sialyltransferase. (1989) (5)
Lymphocytes: A reservoir of latent hepadnavirus infection (1989) (5)
Immune-complex arthritis in viral hepatitis? (1971) (4)
Interferon in clinically stable, replicative chronic hepatitis B: good news for some. (1991) (4)
The liver. Biology and pathobiology. Ed 3: Edited by Irwin M. Arias, James L. Boyer, Nelson Fausto, William B. Jacoby, David Schachter, and David A. Shafritz. 1628 pp. New York: Raven, 1994. $265 (1995) (4)
LABORATORY-ACQUIRED HEPATITIS B (1975) (4)
Inflammatory diseases of the liver. (1975) (4)
CASE REPORT: Terbinafine-Induced Hepatitis and Pancytopenia (2001) (4)
Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration. (1993) (4)
Liver disease in primary care medicine (1980) (4)
Nonresponse to interferon in chronic hepatitis C: re-treatment redux. (2001) (4)
Feedback EEG in the detection of subclinical hepatic encephalopathy: a preliminary report. (1989) (4)
Transforming growth factors in human chronic hepatitis and cirrhosis: correlations with fibrogenesis and hepatic regeneration. (1991) (4)
Diseases of the Liver and Bile Ducts. A Practical Guide to Diagnosis and Treatment. (1998) (4)
Primary amyloidosis presenting as “sicca complex” and severe intrahepatic cholestasis (1972) (4)
Extracellular matrix: Chemistry, biology, and pathobiology with emphasis on the liver. Edited by M. A. Zern and L. M. Reid, 591 Pp. New York: Marcel Dekker, 1993. $195 (1993) (4)
Fat-storing cells and liver fibrosis (1995) (3)
Increased plasma enzyme activity induced by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A). (1972) (3)
Predicting clinical recovery from alcoholic liver disease. (1983) (3)
Pretreatment Evaluation of Chronic Hepatitis C (2015) (3)
Hearing levels in a normal veteran population. Relationship to alcohol consumption. (1973) (3)
Hepatocellular carcinoma in transgenic mice: a consequence of continued expression of the HBx gene? (1992) (3)
Pathogenesis of experimental viral hepatitis (second of two parts). (1974) (3)
Prisoner Blood Donors and Posttransfusion (Icteric) Viral Hepatitis (1967) (3)
Energy metabolism: Tissue determinants and cellular corollaries. Edited by J.M. Kinney and H.N. Tucker. 562 pp. New York: Raven Press, 1992. $56 (1993) (3)
The Effects of a Single, Intravenous Dose of Bumetanide Versus Furosemide in Patients with Ascites and Edema Due to Alcoholic Liver Disease (1981) (3)
Neoglycoconjugates, preparation and applications. Edited by Y. C. Lee and Reiko T. Lee. 549 pp. San Diego: Academic Press, 1994. $120 (1995) (3)
Giving blood: The development of an altruistic identity. J.A. Piliavin and P.L. Callero, 313 pp. Baltimore: Johns Hopkins University Press, 1991. $50 (1992) (3)
Outcomes and costs of care in hepatitis c: combination therapy scores again (2000) (3)
Natural history of acute hepatitis B in adults reexamined. (1987) (3)
Hepatitis B today: New guidelines for the pediatrician-discussion (1993) (2)
Drug-induced hepatic injury. 2nd ed. Edited by B.H.C. Stricker, 560 pp. Amsterdam: Elsevier, 1992. $203 (1993) (2)
Acute Viral Hepatitis (2004) (2)
When and how to screen for liver disease. (2000) (2)
Handbook of critical care. 3rd ed. Edited by J.L. Berk and J.E. Sampliner, 812 pp. Boston: Little, Brown & Co., Inc., 1990. $45 (1991) (2)
Hepatitis B vaccines in clinical practice. Edited by Ronald W. Ellis, 418 pp. New York: Marcel Dekker, 1993. $155 (1994) (2)
Interferon-alpha for chronic hepatitis C: reducing the uncertainties. (1997) (2)
Combination therapy in naive patients with chronic hepatitis C: more value for the money. (2000) (2)
Outcomes and costs of care in hepatitis C: combination therapy scores again. (2000) (2)
Empiric Therapy Based on Clinical Syndrome (2018) (2)
Liver transplantation: more questions. (1987) (2)
A redoubtable obstacle to a hepatitis C vaccine. (1993) (2)
Hepatitis vaccines. (2001) (2)
Elements of graph design. By Stephen M. Kosslyn. 309 pp. New York: Freeman, 1994. $18.95 (1995) (2)
Molecular epidemiology: Principles and practices. Edited by Paul A. Schulte and Frederica P. Perera, 588 pp. San Diego: Academic Press, 1993, $80 (1994) (2)
Cell adhesion molecules in human organ transplants. By G. Steinhoff, 110 pp. Austin: R.G. Landes, 1993. $89.95 (1994) (1)
Drug‐induced liver disease. By Geoffrey C. Farrell, 673 pp. Edinburgh: Churchill Livingstone, 1994. $115 (1995) (1)
Current Concepts of Viral Hepatitis and A Peek into the Future 1 (1974) (1)
Anti-HCV screening of blood donors: the impact in Spain. (1991) (1)
Chronic ethanol feeding decreases mitochondrial glutathione in rats (1988) (1)
Coexistence of raynaud's phenomenon and chronic active hepatitis with hepatitis B antigen. (1974) (1)
Metallothionein in biology and medicine. Edited by C.D. Klaassen and K.T. Suzuki, 414 pp. Boca Raton, FL: CRC Press, 1991. $124.95 (1992) (1)
Immunization with naked DNA: a sexy technique. (1993) (1)
Polymerized human albumin binding with hepatitis B surface antigen (1986) (1)
Interferon-α in Hepatitis C (1997) (1)
Notice on Short Communications (1974) (1)
Therapy for chronic active hepatitis. (1984) (1)
Move over acetaldehyde, here come the fatty acid ethyl esters! (1986) (1)
Bilirubin: A physiologic function, at last? Maybe? (1987) (1)
Chronic Inflammatory Liver Disease: Reexamination in Perspective (1974) (1)
Oxford Textbook of Clinical Hepatology. Edited by N. McIntyre, J.‐P. Benhamou, J. Bircher, M. Rizzetto and J. Rodés, 1,700 pp. Oxford: Oxford University Press, 1991. $250. (1993) (1)
Bockus gastroenterology. ed 5. Edited by William S. Haubrich, Fenton Schaffner, and J. Edward Berk. 4,008 pp. Philadelphia: Saunders, 1995. $595 (1995) (1)
Failure to detect hepatitis B surface antigen (HBsAg) in certified shellfish from New England. (1976) (1)
Hepatitis and information retrieval and use: a seminar for fourth-year medical students. (1982) (1)
Support of the acutely failing liver. Edited by A. A. Demetriou, 134 pp. Austin: R. G. Landes Co., 1994. $89.95 (1995) (1)
Extracellular matrix genes. Edited by L.J. Sandell and C.D. Boyd, 270 pp. San Diego: Academic Press, 1990. $59.95 (1991) (1)
Osteoarthritis of the knee. (2006) (1)
Interferon treatment of chronic non-A, non-B (HCV) hepatitis: the saga continues. (1990) (1)
Acute toxic effects of D-galactosamine on human embryo liver cells in tissue culture. (1972) (1)
Correspondence. Does Ethanol Produce a “Hyperthyroid Hepatic State”? (1984) (1)
Prenylation of the large hepatitis delta virus antigen: a target for antiviral therapy. (1992) (1)
Prometheus' liver: Did the eagle stimulate a specific human hepatocyte growth factor? (1988) (1)
Chapter 3 – Acute viral hepatitis (2004) (0)
Prevention of Viral Hepatitis. (2002) (0)
Reviewer Recognition 2013 (2014) (0)
Viral hepatitis: Current status and issues. By Edouard Kurstak, 217 pp. Vienna: Springer‐Verlag, 1993. $89 (1994) (0)
Hepatitis B and C. Management and Treatment (2002) (0)
INFECTION AND INFECTION CONTROL (1968) (0)
HBV vaccines without HBsAg: Immune mimicry via antiidiotype antibodies (1986) (0)
Rapid induction of gluconeogenesis during fasting. (1992) (0)
Interferon for Chronic Hepatitis B (1996) (0)
Virus and the liver (Falk Symposium 28) (1981) (0)
Liver function. Edited by D.G. Cramp and E.R. Carson, 263 pp. London: Chapman and Hall, 1990. $112.50 (1991) (0)
Comment on: Hepatitis a prevention analysis. Authors' reply (2002) (0)
Molecular and cell biology of the liver. Edited by A.V. LeBouton, 543 pp. Boca Baton, FL: CRC Press 1993. $198 (1994) (0)
Book ReviewOxford Textbook of Medicine (1988) (0)
Human vaccines and vaccination. By M. Mackett and J. D. Williason, 215 Pp. Oxford: Bios Scientific Publishers, 1995. $37.95 (1995) (0)
Book ReviewProgress in Liver Diseases. (1974) (0)
Liver diseases and renal complications (Serono Symposia Series: Advances in experimental medicine, Vol. 3). Edited by P. Gentilini, I.M. Arias, V. Arroyo and R.W. Schrier. New York: Raven Press, 1991. 376 pp. $75 (1991) (0)
Emerging viruses. Edited by S.S. Morse, 317 pp. New York: Oxford University Press, 1993. $39.95 (1994) (0)
The puzzle people: Memoirs of a transplant surgeon. By T.E. Starzl, 364 pages. Pittsburgh, PA: University of Pittsburgh Press, 1992. $24.95 (1993) (0)
Chronic Hepatitis C: Impact, Diagnosis, and Treatment (1998) (0)
Mass hepatitis B vaccination programs for babies of carrier moms: Feasible but costly (1988) (0)
Advanced therapeutic endoscopy. Edited by J.S. Barkin and C.A. O'Phelan, 365 pp. New York: Raven Press, 1990. $110 (1991) (0)
Hans Popper: A tribute. Edited by P. D. Berk, F. Schaffner, and R. Schmid, 191 pp. New York: Raven Press. 1991. $50 (1992) (0)
Secrets of Lecturing: How I Learned to Talk the Talk (2016) (0)
Atlas of clinical gastroenterology. 2nd ed. By J.J. Misiewicz, A. Forbes, A.B. Price, P.J. Shorvon, D.R. Triger and G.N.J. Tytgat. 373 pp. London: Wolfe Publishing, 1994. $125 (1994) (0)
Editorial: Chronic inflammatory liver disease: reexamination in perspective. (1974) (0)
Prevention of viral hepatitis (2002) (0)
Essentials of clinical hepatology. By C. F. Gholson and B. R. Bacon, 286 pp. St. Louis: Mosby-Year Book, 1993. $42 (1993) (0)
Contents, Vol. 19, 1979 (1979) (0)
GABA and benzodiazepine receptor subtypes. Molecular biology, pharmacology, and clinical aspects. Edited by G. Biggio and E. Costa, 239 pp. New York: Raven Press, 1990. $85 (1991) (0)
Toxic injury of the liver, part B. The liver: Normal function and disease series, volume 2: Edited by Emmanuel Farber and Murray M. Fisher. 384 pp., illus., $39.75. Marcel Dekker, Inc., New York, New York, 1980 (1980) (0)
Guide to liver transplantation. Edited by T.L. Fabry and F.M. Klion, 352 pp. New York: Igaku‐Shoin, 1992. $98.50 (1992) (0)
Textbook of gastroenterology. Edited by T. Yamada, D.H. Alpers, C. Owyang, D.W. Powell and F.E. Silverstein, 2,683 pp. Philadelphia: J. B. Lippincott, 1991. $180 (1992) (0)
Intraperitoneal transplantation of hepatocytes attached to dextran beads: Future promises (1987) (0)
Print and Digital Media Review (2014) (0)
Inborn errors of metabolism. Edited by J. Schaub, F. Van Hoof and H.L. Vis, 298 pp. New York: Raven Press, 1991. $62 (1991) (0)
Should health care workers exposed to hepatitis C routinely receive hepatitis A vaccine? (1998) (0)
Toxic injury of the liver (in two parts), part A. (The liver: Normal function and disease series, volume 2) (1980) (0)
Chronic Active Liver Disease. Edited by Sidney Cohen and Roger D. Soloway. ix + 266 pp. Illustrated. New York: Churchill Livingstone, 1983. $36 (1984) (0)
Replication of the hepatitis D virus genome without hepatitis B virus. (1992) (0)
Toxic injury of the liver, part B. The liver: Normal function and disease series, volume 2 (1980) (0)
Changing Concepts in the Epidemiology of Viral Hepatitis (1969) (0)
Mean Plasma Enzyme Activities before and after Surgery (2004) (0)
Microbiology in Blood Transfusion. By John A. J. Barbara, xii + 211 pp. Paperback. Boston: Wright PSG. $15 (1984) (0)
Future therapy for hepatitis B (2007) (0)
A decade of viral hepatitis, abstracts 1969–1979 (1980) (0)
Protection against the transmission of hepatitis B virus in dental practitioners: Better gloves, earlier vaccination, or both? (1989) (0)
Extrahepatic Manifestations in Liver Diseases. Falk Symposium 69. Edited by R. Schmid, L. Bianchi, W. Gerok and K.P. Maier, 401 pp. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1993, $115 (1994) (0)
PRINT AND MEDIA REVIEWS (1999) (0)
Subject Index, Vol. 19, 1979 (1979) (0)
Liver and aging‐1990. Edited by K. Kitani, 364 pp. Amsterdam; Excerpta Medica, 1991. $131.50 (1992) (0)
Scientific American introduction to molecular medicine. Edited by Philip Leder, David A. Clayton, and Edward Rubenstein, 333 pp. New York: Scientific American, 1994. $49 (1995) (0)
Recent advances in the epidemiology and prevention of gallstone disease. Edited by L. Capocaccia, G. Ricci, F. Angelico, M. Angelico, A.F. Attili and L. Lalloni. Dordrecht: Kluwer Academic Publishers, 1991. 165 pp. $90 (1991) (0)
The management of chronic hepatitis B. Discussion (1994) (0)
Hepatobiliary diseases. Edited by J. Prieto, J. Rodés and D.A. Shafritz, 1,128 pp. New York: Springer‐Verlag, 1992. $150. (1993) (0)
Modern concepts in gastroenterology. Vol. 2. Edited by E. Shaffer and A.B.R. Thomson, 319 pp. New York: Plenum Publishing Corp., 1989. $49.50 (1991) (0)
Unraveling the mystery of HDV and its mode of replication: One step forward (1989) (0)
Non-A, non-B hepatitis: finally the big breakthrough. (1989) (0)
HBV/HDV coinfections in parenteral drug abusers: The Worcester story (1988) (0)
Transport in the liver. Edited by D. Keppler and K. Jungermann. 258 pp. Dordrecht: Kluwer Academic Publishers, 1994. $75 (1995) (0)
Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C (2017) (0)
Hepatitis A, R.J. Gerety (Ed.). Academic Press, Inc., Orlando, Florida (1984), 282, $49.00 (1985) (0)
Wright's liver and biliary disease. 3rd ed. Edited by G.H. Millward‐Sadler. R. Wright and M.J.P. Arthur, 1,662 pp. London: W.B. Saunders, 1992. $289 (1993) (0)
And now, the molecular cloning of the hepatitis E virus. (1990) (0)
INTERFERON FOR CHRONIC HEPTITIS B. AUTHORS' REPLY (1996) (0)
Book Reviews (1929) (0)
Outcomes Research in Hepatology (2008) (0)
Prevention and Immunoprophylaxis of Chronic Viral Hepatitis (2002) (0)
Gastroenterologist specialist care is effective and cost-effective compared to care provided by generalists (2000) (0)
Reviewer Recognition 2012 (2013) (0)
Phlebotomy Improves Therapeutic Response to Interferon (INF) in Patients with Chronic Hepatitis C (CHC): A Meta-Analysis of Six Prospective Randomized Controlled Trials (RCT) (2006) (0)
More bang for the buck in Bangkok: using hepatitis B virus vaccine without hepatitis B immune globulin. (1989) (0)
Hepatic transport and bile secretion: Physiology and pathophysiology. Edited by N. Tavoloni and P.D. Berk, 791 pp. New York: Raven Press, 1993.$199 (1993) (0)
Revisiting a Dangerous Alternative (2017) (0)
Systemic Effects of HBsAg Immune Complexes. Edited by Ettore Bartoli, Livio Chiandussi, and Sheila Sherlock. 307 pp. Padova: Piccin Medical Books, 1981. (Price not given.) (2007) (0)
Salicylate hepatitis. (1977) (0)
Hepatitis B: Edited by R. J. Gerety. 470 pp., $79.00. Academic Press, Inc., Orlando, Florida, 1985 (1986) (0)
Liver disease and gallstones: The facts. By A. G. Johnson and D.R. Triger, 121 pp. Oxford, UK: Oxford University Press, 1992. $22.95 (1994) (0)
Hepatic plasma proteins: Mechanisms of function and regulation. By B. H. Bowman, 285 pp. San Diego: Academic Press, inc., 1993. $59.95. (1993) (0)
Hepatitis B e antigen production from hepatitis B core antigen: A proteolytic self-cleavage mechanism (1988) (0)
Infectious diseases of the liver. Falk symposium 54. Edited by L. Bianchi, W. Gerok, K.P. Maier and F. Deinhardt, 386 pp. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1989. $99.50 (1991) (0)
Intravenous interferon-beta in chronic hepatitis B: promises. (1993) (0)
Re: Arguedas et al.—hepatitis A prevention analysis (2002) (0)
Hepatitis delta virus: Molecular biology, pathogenesis and clinical aspects. Edited by S.J. Hadziyannis, J.M. Taylor and F. Bonino, 493 pp. New York: Wiley-Liss, 1993. $124.95. (1993) (0)
Hepatitis in pregnancy. (1986) (0)
Genes and genomes: A Changing Perspective. M. Singer and P. Berg, 929 pp. Mill Valley: University Science Books, 1991. $58.50 (1992) (0)
Manual of gastroenterology: Diagnosis and therapy. 2nd ed. By G.L. Eastwood and C. Avunduk, 497 pp. Boston: Little, Brown, 1994. $34.95 (1994) (0)
Color atlas of liver disease. 2nd ed. Edited by S. Sherlock and J. A. Summerfield, 248 pp. St. Louis: Mosby–Year Book, Inc., 1991. $85 (1992) (0)
Viral hepatitis (Clinical gastroenterology monograph series) (1978) (0)
Recombinant human α-interferon: A promissory note in non-A, non-B chronic hepatitis (1987) (0)
LO, THE HEPATITIC CLAM (1967) (0)
Cirrhosis, hepatic encephalopathy, and ammonium toxicity. Edited by S. Grisolia, V. Felipo and M.D. Minana. 276 pp. Plenum Press, 1991. $69.50 (1992) (0)
Gastrointestinal disease: Pathophysiology/diag-nosis/management. 5th Edition. Edited by M. H. Sleisenger and J. S. Fordtran and Associate Editors B. F. Scharschmidt and M. Feldman, 2445 pp. Philadelphia: W.B. Saunders, 1993. $185 (1994) (0)
Fat-storing cells and liver fibrosis: Edited by C. Surrenti, A. Casini, S. Milani, and M. Pinzani, 380 pp. Dordrecht: Kluwer Academic Publishers, 1994. $117 (1995) (0)
Viral hepatitis: Biological and clinical features, specific diagnosis, and prophylaxis. 2nd ed. By F.B. Hollinger, W.S. Robinson, R.H. Purcell, J.L. Gerin and J. Ticehurst, 204 pp. New York: Raven Press, 1990. $78 (1991) (0)
Viral hepatitis and liver disease. Edited by K. Nishioka, H. Suzuki, S. Mishiro, and T. Oda. 802 pp. Tokyo: Springer‐Verlag, 1994. $260 (1995) (0)
Viral Hepatitis and Delta Infection. Edited by Giorgio Verme, Ferruccio Bonino, and Mario Rizzetto. (Proceedings of an International Symposium on Viral Hepatitis June 10–11, 1983, Torino, Italy), xviii + 421 pp. New York: Alan R. Liss, 1984. $54.00. (1984) (0)
Bile acids and hepatobiliary system. From Basic Science to Clinical Practice. Edited by Gustav Paumgartner, Adolph Stiehl, and Wolfgang Gerok, 328 pp. Dordrecht: Kluwer Academic Publishers, 1994. $100 (1995) (0)
Good news and bad news: Prostaglandins alter the course of fulminant murine hepatitis but the mice die anyway (1988) (0)
Book ReviewViral Hepatitis and Liver Disease (1985) (0)
Diagnosis and management of liver disease. Edited by Ralph Kirsch, Simon Robson, and Charles Trey, Pp. 327. London: Chapman & Hall Medical, 1995. $49 (1995) (0)
Toxic injury of the liver (in two parts), part A. (The liver: Normal function and disease series, volume 2): Edited by Emmanuel Farber and Murray M. Fisher. 496 pp., illus., $47.50. Marcel Dekker, Inc., New York, N.Y., 1979 (1980) (0)
The Clinical Features of Acute Viral Hepatitis (1989) (0)
Book ReviewDiseases of the Liver and Biliary System (1986) (0)
Hepatitis B virus growth in cell culture: Success at last (1987) (0)
Profiles: Raymond S. Koff, MD (2016) (0)
Fatty liver and hyper tri glyceridemia produced by d galactosamine their relationship to fatty acid mobilization (1973) (0)
Viral Hepatitis: Scientific basis and clinical management. Edited by A.J. Zuckerman and H.C. Thomas, 590 pp. Edinburgh: Churchill Livingston, 1993. $150 (1994) (0)
Chronic liver damage. Edited by M.U. Dianzani and P. Gentilini, 314 pp. Amsterdam: Excerpta Medica, 1990. $120 (1991) (0)
Virus and the liver (Falk Symposium 28): Edited by L. Bianchi, W. Gerok, K. Sickinger, and G. A. Stalder. 424 pp., £24.95. MTP Press Limited, Lancaster, England, 1980 (1981) (0)
The gang of four expands: Introducing tree squirrel hepatitis B virus (1987) (0)
Selected summaryThe gang of four expands: Introducing tree squirrel hepatitis B virus (1987) (0)
Clinical nutrition: Parenteral nutrition. 2nd Ed. Edited by J.L. Rombeau and M.D. Caldwell, 889 pp. Philadelphia: W.B. Saunders, 1993. $105 (1994) (0)
Practical liver biopsy interpretation: Diagnostic algorithms. By J. Ludwig, 301 pp. Chicago: ASCP Press, 1992. $55 (1993) (0)
The hepatitis delta virus. Edited by J.L. Gerin, R.H. Purcell and M. Rizzetto, 481 pp. New York: Wiley‐Liss, Inc, 1991. $125.00 (1992) (0)
Gastroenterology and hepatology. (1995) (0)
Clinical/International/Special Interest Tracks: Treatment of Chronic Viral Hepatitis (1998) (0)
Transplantation of the liver. Ed 2. Edited by Willis C. Maddrey and Michael F. Sorrell, 640 Pp. Norwalk: Appleton & Lange, 1995. $135 (1995) (0)
Periodic Liver Biopsy for Mild Hepatitis C (2001) (0)
Liver gene expression: Edited by Francois Tronche and Moshe Yaniv, 350 pp. Austin: R. G. Landes Co, 1994. $89.95 (1995) (0)
Selected Abstracts of the Research Forum of the Société Nationale Française de Gastroentérologie, November 18-19, 1972, Brussels, Belgium (1973) (0)
Liver transplantation, clinical teaching project. American Gastroenterological Association. Unit 7. By S.R. Vera, C.A. Riely, M.I. Burrell and R.S. Koff, Timonium, MD: Milner-Fenwick Inc., 1993. $100. (1993) (0)
Gastrointestinal and hepatic immunology. Edited by Richard V. Heatley. 394 pp. Cambridge: Cambridge University Press, 1994. $110 (1995) (0)
Etiology, pathology and treatment of hepatocellular carcinoma in North America. Edited by E. Tabor, A.M. Di Bisceglie and R.H. Purcell. Houston: Gulf Publishing Co., 1991. $80 (1991) (0)
Liver biopsy interpretation. Ed 5. By Peter J. Scheuer and Jay H. Lefkowitch, 315 pp. London: Saunders, 1994. $50 (1995) (0)
Acetaldehyde and the fetal alcohol syndrome (1989) (0)
Primary liver cancer: Etiological and progression factors. Edited by Christian Brechot, 311 pp. Boca Raton, FL: CRC Press, 1994. $179.95 (1995) (0)
Liver biopsy interpretation (1995) (0)
Medical and nutritional complications of alcoholism. Mechanisms and management. Edited by C.S. Lieber, 579 pp. New York: Plenum Medical Book Company, 1992, $89.50 (1993) (0)
Cell death mechanisms of acute and lethal cell injury. Edited by W.J. Mergner, R. T. Jones and B. F. Trump, 263 pp. New York: W.W. Morton, 1990. $110 (1991) (0)
Gastroenterology in practice. By I.G. Barrison, M.G. Anderson, and P.B. McIntyre, 110 pp. London: Gower, 1992. $49.95 (1993) (0)
Autoimmune liver diseases. Edited by E.L. Krawitt and R.H. Weisner, 376 pp. New York: Raven Press, 1991. $89 (1991) (0)
Current hepatology. Vol. 10. Edited by Gary Gitnick, 357 pp. Chicago: Year Book Medical Publishers, Inc., 1990. $74.95. (1991) (0)
Cells of the hepatic sinusoid. Volume 4. Edited by D.L. Knook and E. Wisse, 612 pp. Leiden, The Netherlands: The Kupffer Cell Foundation, 1993. $115 (1994) (0)
Cost Effectiveness of Treating Chronic Hepatitis B and C (1998) (0)
Biopsy diagnosis of liver disease. By D.C. Snover, 300 pp. Baltimore: Williams & Wilkins, 1992. $75 (1992) (0)
Apoptosis. Edited by Enrico Mihich and Robert T. Schimke. 272 pp. New York: Plenum, 1994. $89.50 (1995) (0)
Uncommon Bile Duct Injuries and Interventions (2017) (0)
Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and prognosis: Edited by Carroll M. Leevy, Sheila Sherlock, Neils Tygstrup, and Rowen Zetterman, 205 pp. New York: Raven Press, 1994. $40. (1995) (0)
Interferon-alpha in hepatitis C. (1997) (0)
Serum hepatitis in urban adults. (1970) (0)
Acute and Chronic Hepatitis B (1989) (0)
Re: Arguedas et al.--Hepatitis A prevention analysis. (2002) (0)
The Human Liver: A Scanning Electron Microscopic Atlas. By F.‐J. Vonnahme. Basel: Karger, 1993. 100 pp. $65.75 (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Raymond S. Koff?

Raymond S. Koff is affiliated with the following schools:

University of Connecticut